- July 25, 2022Should You Be Worried About Monkeypox? | India Development Debate
Times Now News — July 25, 2022. How worried should we be about the monkeypox threat? We deep-dive on the India Development Debate with Ramanan Laxminarayan, epidemiologist & economist.
Read moreRead more Read More
- July 15, 2022Research calls for regulators to accelerate the approval of antibiotics
European Pharmaceutical Review — July 15, 2022. Director of One Health Trust, Dr Ramanan Laxminarayan, commented: “Antibiotics are different from other drugs in many respects, including the need for the periodic introduction of new drugs to replace ones to which resistance has developed and the complexity of trials to identify drugs that are effective against […]
Read moreRead more Read More - May 12, 2022What would it cost to raise childhood vaccination coverage to at least 90% in every district in India?
Immunization Economics — May 12, 2022. A new study presenting updated estimates of the budgetary impact of India’s routine childhood vaccination program has been published by researchers from One Health Trust (formerly CDDEP) and other organizations in Health Policy and Planning.
Read moreRead more Read More - April 19, 2022Scientists allay fears of new COVID wave, say cases rising but focus on hospital admissions
The New Indian Express — April 19, 2022. “Testing has gone down and we are likely missing cases but I would focus on hospitalisations rather than caseloads given where we are in the pandemic,” Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy in Washington and New Delhi, told PTI.
Read moreRead more Read More - April 12, 2022Greater access to antibiotics is essential for curbing drug resistance
Financial Times — April 12, 2022. “There is now growing — if still grossly inadequate — attention being paid to preventing resistance and developing new drugs. But the international response has largely ignored the matter of access to them, to the detriment of immediate health needs and the long-term effort to curb drug-resistant infections,” Ramanan […]
Read moreRead more Read More - April 11, 2022Antibiotic-Free Claims on Animal Products Can’t Be Trusted, New Study Finds
VegNews — April 11, 2022. “This paper is the first to track antibiotic resistance in animals globally and it finds that resistance has gone up dramatically during the past 18 years,” report co-author Ramanan Laxminarayan said in a statement. “We certainly do want higher-protein diets for many people, but if this comes at the cost […]
Read moreRead more Read More - April 8, 2022Mask mandate may not be necessary for now, say experts
The Tribune — April 8, 2022. “The issue is of compliance fatigue,” Ramanan Laxminarayan, director of Washington’s Center for Disease Dynamics, Economics & Policy.
Read moreRead more Read More - April 7, 2022Mask mandate may not be necessary for now, say experts on India’s COVID situation
The New Indian Express — April 7, 2022. “The issue is of compliance fatigue,” Ramanan Laxminarayan, director of Washington’s Center for Disease Dynamics, Economics & Policy.
Read moreRead more Read More - March 23, 2022CDDEP researchers reveal birth weight’s impact on cognitive development during childhood.
CDDEP researchers show that low-birth-weight infants experience lower test scores compared with normal birth weight infants. Health policies designed to improve birth weight could improve human capital in resource-poor settings.
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.
